{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:15:26Z","timestamp":1762161326176,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.4158\/ep171917.or","type":"journal-article","created":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T10:21:39Z","timestamp":1502965299000},"page":"1289-1296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluating the Prescription of Angiotensin-Converting Enzyme Inhibitors or Receptor Blockers in Patients with Diabetes in Jordan"],"prefix":"10.1016","volume":"23","author":[{"given":"Fadia","family":"Mayyas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waed","family":"Bataineh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anan","family":"Jarab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP171917.OR_bb0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2251-6581-12-14","article-title":"Role of self-care in management of diabetes mellitus","volume":"12","author":"Shrivastava","year":"2013","journal-title":"J Diabetes Metab Disord"},{"key":"10.4158\/EP171917.OR_bb0015","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.diabres.2013.02.005","article-title":"Update of mortality attributable to diabetes for the IDF Diabetes Atlas: estimates for the year 2011","volume":"100","author":"IDF Diabetes Atlas Group","year":"2013","journal-title":"Diabetes Res Clin Pract"},{"key":"10.4158\/EP171917.OR_bb0020","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jdiacomp.2007.01.004","article-title":"An increase in prevalence of diabetes mellitus in Jordan over 10 years","volume":"22","author":"Ajlouni","year":"2008","journal-title":"J Diabetes Complications"},{"key":"10.4158\/EP171917.OR_bb0025","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1681\/ASN.2012070718","article-title":"Kidney disease and increased mortality risk in type 2 diabetes","volume":"24","author":"Afkarian","year":"2013","journal-title":"J Am Soc Neph"},{"key":"10.4158\/EP171917.OR_bb0030","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1056\/NEJMoa1310799","article-title":"Changes in diabetes-related complications in the United States, 1990\u20132010","volume":"370","author":"Gregg","year":"2014","journal-title":"N Engl J Med"},{"key":"10.4158\/EP171917.OR_bb0035","first-page":"17","article-title":"Type II diabetes mellitus and cardiovascular risk factors: current therapeutic approaches","volume":"12","author":"Kalofoutis","year":"2007","journal-title":"Exp Clin Cardiol"},{"key":"10.4158\/EP171917.OR_bb0040","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-1-4614-5441-0_11","article-title":"Nephropathy in diabetes","volume":"771","author":"Satirapoj","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"10.4158\/EP171917.OR_bb0045","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ccl.2010.04.006","article-title":"Diabetes, cardiovascular risk and nephropathy","volume":"28","author":"Hahr","year":"2010","journal-title":"Cardiol Clin"},{"key":"10.4158\/EP171917.OR_bb0050","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.dsx.2012.08.005","article-title":"ACE inhibitors or ARBs for diabetic nephropathy: the unrelenting debate","volume":"6","author":"Kota","year":"2012","journal-title":"Diabetes Metab Syndr"},{"key":"10.4158\/EP171917.OR_bb0055","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/sj.jhh.1002101","article-title":"Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade","volume":"21","author":"Dandona","year":"2007","journal-title":"J Hum Hypertens"},{"key":"10.4158\/EP171917.OR_bb0060","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11892-007-0074-7","article-title":"Microalbuminuria as a target to improve cardiovascular and renal outcomes in diabetic patients","volume":"7","author":"Basi","year":"2007","journal-title":"Curr Diab Rep"},{"key":"10.4158\/EP171917.OR_bb0065","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.2337\/dci15-0012","article-title":"Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association","volume":"38","author":"Fox","year":"2015","journal-title":"Diabetes Care"},{"key":"10.4158\/EP171917.OR_bb0070","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"10.4158\/EP171917.OR_bb0075","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"suppl 1","key":"10.4158\/EP171917.OR_bb0080","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.2337\/dc17-S012","article-title":"Cardiovascular disease and risk management","volume":"40","author":"American Diabetes Association","year":"2017","journal-title":"Diabetes Care"},{"key":"10.4158\/EP171917.OR_bb0085","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mayocp.2015.10.019","article-title":"Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in patients without heart failure? Insights from 254,301 patients from randomized trials","volume":"91","author":"Bangalore","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.4158\/EP171917.OR_bb0090","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/jama.2012.216237","article-title":"Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial","volume":"309","author":"Ahimastos","year":"2013","journal-title":"JAMA"},{"key":"10.4158\/EP171917.OR_bb0095","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s11892-008-0037-7","article-title":"Antihypertensive medications and their effects on lipid metabolism","volume":"8","author":"Deshmukh","year":"2008","journal-title":"Curr Diab Rep"},{"key":"10.4158\/EP171917.OR_bb0100","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1525-1497.2006.00351.x","article-title":"Indications for and utilization of ACE inhibitors in older individuals with diabetes. Findings from the National Health and Nutrition Examination Survey 1999 to 2002","volume":"21","author":"Rosen","year":"2006","journal-title":"J Gen Intern Med"},{"key":"10.4158\/EP171917.OR_bb0105","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.clinthera.2014.11.011","article-title":"Utilization patterns of anti-hypertensive drugs among the chronic kidney disease population in the United States: a cross-sectional analysis of the National Health and Nutrition Examination Survey","volume":"37","author":"Sonawane","year":"2015","journal-title":"Clin Ther"},{"key":"10.4158\/EP171917.OR_bb0110","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.healthpol.2010.11.010","article-title":"Underuse of ACE inhibitors and angiotensin II receptor blockers among patients with diabetic nephropathy in Taiwan","volume":"100","author":"Yeh","year":"2011","journal-title":"Health Policy"},{"key":"10.4158\/EP171917.OR_bb0115","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.4158\/EP171917.OR_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10157-014-1057-z","article-title":"A new classification of diabetic nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy","volume":"19","author":"Haneda","year":"2015","journal-title":"Clin Exp Nephrol"},{"key":"10.4158\/EP171917.OR_bb0125","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1161\/CIR.0b013e3182776f83","volume":"126","author":"Fihn","year":"2012","journal-title":"Circulation"},{"key":"10.4158\/EP171917.OR_bb0130","doi-asserted-by":"crossref","first-page":"e0116970","DOI":"10.1371\/journal.pone.0116970","article-title":"ACEI\/ARB underused in patients with type 2 diabetes in Chinese population (CCMR-3B study)","volume":"10","author":"Xie","year":"2015","journal-title":"PloS One"},{"key":"10.4158\/EP171917.OR_bb0135","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4037\/ccn2008.28.5.54","article-title":"Improving medication adherence in chronic cardiovascular disease","volume":"28","author":"Albert","year":"2008","journal-title":"Crit Care Nurse"},{"key":"10.4158\/EP171917.OR_bb0140","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s11096-016-0282-9","article-title":"Adherence in outpatients taking warfarin and its effect on anticoagulation control in Jordan","volume":"38","author":"Ababneh","year":"2016","journal-title":"Int J Clin Pharm"},{"key":"10.4158\/EP171917.OR_bb0145","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.sapharm.2015.11.006","article-title":"The association between health beliefs and medication adherence among patients with type 2 diabetes","volume":"12","author":"Alatawi","year":"2016","journal-title":"Res Social Adm Pharm"},{"key":"10.4158\/EP171917.OR_bb0150","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jegh.2014.05.005","article-title":"Adherence to medications and associated factors: a cross-sectional study among Palestinian hypertensive patients","volume":"5","author":"Al-Ramahi","year":"2015","journal-title":"J Epidemiol Glob Health"},{"key":"10.4158\/EP171917.OR_bb0155","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s11096-015-0086-3","article-title":"The influence of patients' knowledge on adherence to their chronic medications: a cross-sectional study in Jordan","volume":"37","author":"Awwad","year":"2015","journal-title":"Int J Clin Pharm"},{"key":"10.4158\/EP171917.OR_bb0160","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/1477-7525-11-191","article-title":"Relationship of treatment satisfaction to medication adherence: findings from a cross-sectional survey among hypertensive patients in Palestine","volume":"11","author":"Zyoud","year":"2013","journal-title":"Health Qual Life Outcomes"},{"key":"10.4158\/EP171917.OR_bb0165","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/10641963.2016.1247164","article-title":"Self-reported adherence to therapeutic regimens among patients with hypertension","volume":"39","author":"Al-Daken","year":"2017","journal-title":"Clin Exp Hypertens"},{"key":"10.4158\/EP171917.OR_bb0170","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s11606-009-1242-z","article-title":"High-risk diabetic patients in Medicare Part D programs: are they getting the recommended ACEI\/ARB therapy?","volume":"25","author":"Yang","year":"2010","journal-title":"J Gen Intern Med"},{"key":"10.4158\/EP171917.OR_bb0175","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF03261835","article-title":"Tolerability of angiotensin-receptor blockers in patients with intolerance to angiotensin-converting enzyme inhibitors: a systematic review and meta-analysis","volume":"12","author":"Caldeira","year":"2012","journal-title":"Am J Cardiovasc Drugs"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20352216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20352216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:03:04Z","timestamp":1761516184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20352216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S1530891X20352216"],"URL":"https:\/\/doi.org\/10.4158\/ep171917.or","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the Prescription of Angiotensin-Converting Enzyme Inhibitors or Receptor Blockers in Patients with Diabetes in Jordan","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP171917.OR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}